9 years old | 0
    female | 0
    eastern Indian origin | 0
    no significant past medical history | 0
    admitted to the emergency room | 0
    abdominal pain | -72
    fever | -72
    nausea | -72
    vomiting | -72
    completed Pfizer-BioNTech COVID-19 immunization series | -744
    SARS-CoV-2 PCR test positive | -384
    asymptomatic at the time of test | -384
    rapid antigen test negative | -384
    traveled to US Virgin Islands | -384 to -288
    multiple mosquito bites | -384 to -288
    persistent fever | -72 to -24
    emesis | -72 to -24
    nausea (persistent) | -72 to -24
    abdominal pain (persistent) | -72 to -24
    respiratory viral PCR panel negative | -24
    oseltamivir dose | -24
    decreased intake | -24
    painful area at the tip of the tongue | -24
    persistent symptoms leading to emergency department | 0
    maximum temperature 40Â°C | 0
    heart rate 124-133 bpm | 0
    respiratory rate 20/30 breaths/min | 0
    oxygen saturation 96% to 100% | 0
    blood pressure 94-102/44-54 mm Hg | 0
    mild conjunctival injection | 0
    epigastric abdominal tenderness | 0
    hyponatremia | 0
    leukopenia | 0
    thrombocytopenia | 0
    lymphopenia | 0
    elevated inflammatory markers | 0
    SARS-CoV-2 PCR negative | 0
    rapid streptococcal antigen test negative | 0
    urinalysis abnormalities | 0
    IVIG started | 0
    ceftriaxone started | 0
    doxycycline started | 0
    antibiotics discontinued after 72 hours | 72
    negative cultures | 72
    parasite and viral testing sent | 0
    macular nonpruritic nonpetechial rash | 5
    rash over neck and hands | 5
    sparing of palm and soles | 5
    bilateral conjunctival injection | 24
    resolved conjunctival injection | 168
    afebrile after IVIG completion | 24
    prednisone started | 0
    confusion episodes | 24
    agitation episodes | 24
    DVT prophylaxis initiated | 0
    anticoagulation discontinued | 0
    aspirin not started | 0
    unremarkable echocardiogram | 0
    inflammatory markers trended downward | 72
    pancytopenia persisted | 72
    hemoglobin nadir 9.7 g/dL | 72
    RBC count nadir 3.61 M/uL | 72
    platelet count nadir 30,000/uL | 72
    WBC count nadir 2580 cells/uL | 72
    absolute lymphocyte count nadir 240 | 72
    BNP peak 4114 pg/mL | 72
    BNP down trended to 429 pg/mL | 168
    normal echocardiography | 0, 72, 168
    complement levels normal | 72
    ANA positive 1:320 | 72
    dsDNA normal | 72
    Smith antibodies normal | 72
    IL-6 elevated | 72
    CXCL-9 elevated | 72
    negative DAT | 72
    peripheral smear negative for blasts | 72
    bone marrow aspiration not performed | 72
    thrombocytopenia improved on day 7 | 168
    platelet count 104,000/uL at discharge | 168
    met criteria for MIS-C | 0
    recent positive COVID-19 PCR | -384
    fever | -72 to -24
    gastrointestinal symptoms | -72 to -24
    broad differential diagnosis | 0
    negative infectious disease tests | 72
    considered HLH | 72
    considered ITP | 72
    considered DIT | 72
    considered MAS | 72
    considered sHLH | 72
    considered systemic juvenile idiopathic arthritis | 72
    considered malignancy | 72
    platelet count recovery | 168
    ALC recovery | 168
    WBC recovery | 168
    Hgb recovery | 168
    mild persistent fatigue after 2 months | 168
    follow-up by specialists | 168
    no alternative diagnosis within 4 months | 168
    multi-specialty team utilized | 0
    IVIG treatment completed | 24
    steroids tapered | 72
    thrombocytopenia resolution | 168
    discharged | 168